Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Alibaba Health Information Technology (TWY) AI Stock Analysis

2 Followers
DE:TWY

Alibaba Health Information Technology

(Frankfurt:TWY)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Conservative Balance SheetExtremely low leverage gives Alibaba Health substantial financial resilience and reduces interest and refinancing pressure. Growing equity alongside earnings provides a stronger capital base, preserving flexibility to invest in healthcare platforms, products, and services through changing conditions.
Negative Factors
Decelerating Revenue GrowthRecent top-line growth has slowed sharply after the company’s earlier expansion, which may limit operating leverage and reduce the pace at which earnings can compound. Continued deceleration would make it harder to absorb fixed platform costs and sustain improving profitability.

Alibaba Health Information Technology (TWY) vs. iShares MSCI Germany ETF (EWG)

-60%-40%-20%0%20%40%DE:TWY-44.73%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 5.27B
Dividend Yield
2.32%
Average Volume (3M)
4,632
Price to Earnings (P/E)
20.3
Beta (1Y)
0.90
Revenue Growth
5.35%
EPS Growth
26.96%
Country
Germany
Employees
1,394
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Alibaba Health Information Technology Business Overview & Revenue Model

Company Description

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company...

Alibaba Health Information Technology Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:TWY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:2192HK:219270OutperformHKD 4.57B11.427.05%5.08%6.47%8.10%
HK:1833HK:183370NeutralHKD 11.53B20.614.62%―7.92%152.75%
HK:1099HK:109965NeutralHKD 52.02B6.308.33%4.74%2.78%7.71%
HK:2607HK:260758NeutralHKD 62.90B11.606.64%6.01%9.12%-3.22%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
HK:2158HK:215848NeutralHKD 2.47B30.011.88%1.72%16.87%―

* Healthcare Sector Average

Performance Comparison

-50%-25%0%25%DE:TWYHK:1833HK:2607HK:1099HK:2158HK:2192Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:TWY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:TWYAlibaba Health Information Technology 0.33-0.27-45.74%
HK:1833Ping An Healthcare and Technology Company 5.33-9.55-64.15%
HK:2607Shanghai Pharmaceuticals Holding Co Class H10.87-0.69-5.94%
HK:1099Sinopharm Group Co Class H16.67-3.41-16.97%
HK:2158Yidu Tech, Inc.2.32-2.86-55.26%
HK:2192Medlive Technology Co., Ltd.6.18-3.59-36.73%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.